Aardvark Therapeutics, Inc. Common Stock (AARD) vs enGene Holdings Inc. (ENGN)

A side-by-side comparison of Aardvark Therapeutics, Inc. Common Stock and enGene Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AARD

Aardvark Therapeutics, Inc. Common Stock

$109M

$4.96HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT

ENGN

enGene Holdings Inc.

$121M

$1.81HealthcareDelayed quote: Oct 6, 2026, 3:39 PM EDT

Total return — AARD vs ENGN

growth of $100 · dividends reinvested · last 2y

AARD -63.5% (-39.6%/yr)ENGN -70.1% (-45.3%/yr)AARD compounded faster over this window

AARD ENGN

AARD vs ENGN: by the numbers

•ENGN is the larger company ($121M vs $109M market cap).

Metrics side by side

Valuation

Metric	AARD	ENGN
P/B ratio	1.45	0.53

Profitability

Metric	AARD	ENGN
Gross margin	0.00%	0.00%
Operating margin	0.00%	0.00%
Net margin	0.00%	0.00%
ROE	-93.44%	-2.13%
ROIC	-97.99%	-1.78%

Go deeper

Full AARD analysis Full ENGN analysis Interactive comparison tool

Dig into the metrics

Aardvark Therapeutics, Inc. Common Stock ROE enGene ROE Aardvark Therapeutics, Inc. Common Stock operating margin enGene operating margin Aardvark Therapeutics, Inc. Common Stock revenue growth enGene revenue growth Aardvark Therapeutics, Inc. Common Stock free cash flow enGene free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.